7-BROMO-2,4-DICHLORO-6-FLUOROQUINAZOLINE, 95.0%, 1g

methyl 1-[(4-methylphenyl)sulfonyl]-4-piperidinecarboxylate, 95%, 5g

(S)-Ethyl 2-(3-amino-2-oxopiperidin-1-yl)acetate hydrochloride, 95.0%, 1g

2-Thiazolamine, 4-(tetrahydro-2H-pyran-4-yl)-, 96%, 100mg

2-(Dihydro-2H-pyran-4(3H)-ylidene)acetonitrile, 95.0%, 5g

Prohibition signs in accordance with ISO 7010 Adhesive film, Smoking prohibited, 200 mm, 1 piece

1-(6-Chloro-5-methylpyridin-3-yl)ethanone, 95.0%, 250mg

4-Chlorophenol, >=98%, for synthesis, 250 g, glass packaging

ethyl 4-chlorobenzo[h]quinoline-3-carboxylate, 97%, 500mg

1-(3-tert-butyl-4-methoxyphenyl)ethanone, 5g

4-Bromo-2-(difluoromethyl)pyridine, 95.0%, 100mg

Acetic acid, min. 99%, for synthesis, 5 l, plastic packaging.

tert-Butyl N-(4-ethynyl-1-bicyclo[2.2.2]octanyl)carbamate, 98%, 250mg